May is Brain Tumour Awareness Month – the month to highlight the significance and importance of further advancing research in the management of this challenging cancer. Brain tumours affect people of all ages – they are more common as people get older, however can also occur relatively frequently in the younger population. In Manitoba in 2020, there were 100 new cases of high-grade brain tumours diagnosed. CancerCare Manitoba oncologists and their care teams care for these individuals of all ages.
The survival rate for brain cancer patients varies widely with different types of brain tumours. Many patients with low-grade tumours have excellent survival and prognosis; this is unfortunately not the case in high-grade tumours. Brain cancer takes the lives of more people under the age of 40 than any other cancer.
Significant progress has been made in the management of brain tumours and research continues to improve the survival and quality of life for patients with brain tumours. Several promising projects are looking at all aspects of brain tumour management including surgery, radiology, pathology, radiation and chemotherapy.
CancerCare Manitoba and the Central Nervous System (CNS) (Brain) Disease Site Group are actively involved in international, national and home-grown clinical trials. These green shoots will help to pave the way for better outcomes for brain tumour patients.